Picard Medical, Inc. (PMI) Stock Price
PMIStock
$12.75
Market Cap$29.82M
P/E—
PEG Ratio—
Div yield—
Beta-1.98
PMI Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-83.09%
Price vs S&P 500 (4W)204.18%
VGM Score62.36
PMI Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$1.50 | -$3.05 | -103.33%(-$1.55) |
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
PMIPicard Medical, Inc. | D | A | B | 4.7x | — | 18.6% | -395.5% | $12.75 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
About Picard Medical, Inc.
Picard Medical develops and manufactures implantable Total Artificial Heart (TAH) systems designed to replace the function of a failed human heart. Through its wholly owned medical technology subsidiary, the company focuses on serving patients with advanced heart failure who have limited treatment options.